Top Stories
The findings point to a potential new way to monitor the disease without repeated tissue biopsies.
The money will fund a pivotal trial of StimCardio's Rhyvive wearable following promising early results.
The company's virtual mental health business saw insurance-covered therapy revenue reach $32.1 million, helping offset a sharp decline in direct-to-consumer sales.
Etcelera was born from the bones of Cellarity, Etiome and Empress Therapeutics.
The findings could help refine patient selection and shape the design of future stroke trials.
Conference News
ACLF – Advancing a multi-target therapeutic strategyGENFIT to host a scientific event on November 8, 2026 to outline its ACLF strategy and unveil a comprehensive clinical data package supporting the a...
Extra-wide-bore, cable-less ceiling gantry and real-time digital twin aim to keep cases moving, regardless of procedure type or patient sizeAI-powered precision imaging designed to automatically balan...
New fixed, single-room configuration is designed to make DeepOCT+NIRS Imaging and X1-FFR physiology readily available for efficient cath lab workflows At TCT 2026, Philips will showcase its broader fu...
30-Oct-2026 at 2:25 PM EDT, by Johns Hopkins Medicine contact patient servicesCredit: Johns Hopkins MedicineAs cardiologists, clinicians and researchers convene in Chicago for the American Heart Assoc...
Press Release Biocartis NV: Biocartis to Present Initial ...
